Israel Englander Cerevel Therapeutics Holdings, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 756,000 shares of CERE stock, worth $0. This represents 0.01% of its overall portfolio holdings.
Number of Shares
756,000
Previous 101,400
645.56%
Holding current value
$0
Previous $4.29 Million
621.23%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CERE
# of Institutions
147Shares Held
127MCall Options Held
1.91MPut Options Held
2.7M-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.33MShares$03.86% of portfolio
-
Pentwater Capital Management LP Naples, FL1.88MShares$00.99% of portfolio
-
Marshall Wace, LLP London, X01.87MShares$00.11% of portfolio
-
Segantii Capital Management LTD1.14MShares$05.99% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...